Gut peptides in the treatment of diabetes mellitus

Author： Vahl Torsten P D’Alessio David A

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.13, Iss.3, 2004-03, pp. : 177-188

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Peptides under Development for the Treatment of Type 1 and Type 2 Diabetes Mellitus

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 1, 2002-04 ,pp. : 63-82

Bentham Science Publishers

Access to resources Recommend Favorite

Adipokines in the treatment of diabetes mellitus and obesity

By Catalán Victoria Gómez-Ambrosi Javier Rodríguez Amaia Salvador Javier Frühbeck Gema

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 2, 2009-02 ,pp. : 239-254

Informa Healthcare

Access to resources Recommend Favorite

Ketoconazole enantiomer for the treatment of diabetes mellitus

By Arakaki Richard Welles Bernice

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 185-194

Informa Healthcare

Access to resources Recommend Favorite

Marine Peptides as Potential Agents for the Management of Type 2 Diabetes Mellitus—A Prospect

By Xia En-Qin Zhu Shan-Shan He Min-Jing Luo Fei Fu Cheng-Zhan Zou Tang-Bin

Marine Drugs, Vol. 15, Iss. 4, 2017-03 ,pp. : 88-88

MDPI

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M. Jarvis B.

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite